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Background
Myotonic dystrophy type II (formerly denoted as proxi-
mal myotonic myopathy (PROMM)) is an autosomal
dominantly inherited disease [1]. Sufferers are afflicted
with skeletal muscle (SM) symptoms. Histopathologic
changes of the SM include mild fibrosis and fatty degen-
eration[2]. The multisystemic disorder is also character-
ized by endocrine and metabolism disorder such as
hypercholesterolemia and diabetes mellitus type II as
well as cardiac arrhythmias [1]. The aim of this study is
to evaluate myocardial structural abnormalities in pre-
served ejection fraction (EF).
Methods
We prospectively enrolled 28 subjects (age 53.1 ± 10.7 y,
20 women) with a genetically confirmed diagnosis of
PROMM. The criteria for exclusion were known cardiac
diseases and contraindication for CMR. We assessed
biplanar left-ventricular (LV) volumes, mass and func-
tion applying cine imaging (TR 247.42 ms, TE 1.14 ms,
FOV 340 ms, matrix 192×192, slice thickness 6 mm)
using a 1.5 T Scanner (Avanto, Siemens Healthcare,
Germany, 12 channel surface coil). Late enhancement
imaging (LGE) (GRE, TR 800 ms, TE 5.02 ms, FOV 350
ms, matrix 256×256, slice thickness 7 mm) was per-
formed to detect myocardial fibrosis about 10 minutes
after injection of gadoteridol (0.2 mmol/kgbw). Further-
more, we used a previously described fat/water sequence
[3] (multi-echo GRE, 4-echos, TE 1.53-8.42 ms, FOV
360 mm, matrix 256×256, slice thickness 6 mm) to
identify myocardial fat deposits. Data were analyzed
using cvi42 (circle cardiovascular imaging Inc., Canada).
Results
24 data sets were completed (age 53.8 ± 10.9 y, EF
65.2 ± 5.8%, 17 women). All applied sequences were
evaluable besides 3 fat/water images due to artifacts.
None of the patients had wall motion abnormalities.
Myocardial fibrosis were noticeable in 5 of the 24 sub-
jects (2 women). No significant differences of age (p =
0.24) and LVEF (p = 0.09) were found between positive
and negative LGE (Figure 1). These fibrous changes
were mostly localized subepicardial inferolateral basal.
No fat deposit was found in this region (Figure 1).
Interestingly, small myocardial fat deposits were identi-
fied in the apical portion of the interventricular sep-
tum in 2 patients (Figure 2).
Conclusions
To the best of our knowledge this is the first systematic
CMR study in patients with PROMM. Although all
patients had preserved LVEF we could detect myocardial
fibrosis in one fifth of all patients, suggesting CMR is
feasible to detect such subclinical myocardial manifesta-
tions. Interestingly, we could also detect fat deposits.
Further studies to look for diffuse alterations and corre-
lations to clinical events should come next.
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Figure 1 (A) Detected subepicardial LGE (arrows) in a patient with PROMM. (B) Comparison of LGE positive to negative subjects. BMI: Body
mass index, EF: ejection fraction, LV-EDV-Index: left-ventricular-enddiastolic volume-index.
Figure 2 (A) Indicated fat deposit (arrows) in a patient with PROMM. The view shows both the water and the fat-seperated image. (B)
Comparison of the subjects who have fat deposits with those who have no detected myocardial fat. BMI: Body mass index, EF: ejection fraction,
LV-EDV-Index: left-ventricular-enddiastolic volume-index.
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